肥厚型心肌病患儿全身麻醉后的结局
该研究回顾了2000至2016年间86例肥厚型心肌病(HCM)患儿接受的164次全身麻醉(GA)。143次(87%)无围术期并发症,20例(12%)出现轻微并发症,1例(占GA次数的0.6%)在麻醉诱导时发生心脏骤停并于3天后死亡;年龄、最大室壁厚度、左室流出道(LVOT)压差及收缩/舒张功能不全等临床参数与并发症风险升高无关。
要点
- 专家中心内HCM患儿全麻围术期死亡率0.6%,轻微并发症发生率12%。
- 常见轻微并发症为低血压(15例)和心动过缓(4例)。
- 年龄、最大室壁厚度、LVOT压差及心功能不全未显示与并发症风险升高相关。
核心结论
- 在专家中心,肥厚型心肌病患儿接受全身麻醉的围术期死亡率较低(0.6%),轻微并发症发生率为12%。
- 本研究未发现年龄、最大室壁厚度、LVOT压差或收缩/舒张功能不全与并发症风险升高相关。
研究设计与样本
- 回顾性队列研究,纳入2000至2016年间接受全身麻醉的全部18岁以下肥厚型心肌病患儿。
- 共86例患儿(中位年龄12.4岁,IQR 6.5~14.9),接受164次独立全身麻醉操作。
主要发现
- 病因构成:非综合征性疾病44例(56%)、畸形综合征22例(26%)、先天性代谢缺陷10例(12%)、神经肌肉疾病4例(5%)。
- 麻醉时超声心动图平均最大室壁厚度19 mm(SD±8 mm),23例(14%)为严重左心室肥厚(MWT>30 mm),35例(21%)存在血流动力学显著的LVOT压差(>50 mm Hg)。
- 143次(87%)无围术期并发症;20例(12%)出现轻微并发症:低血压15例、心动过缓4例、短暂ST段改变1例。
- 1例(占GA次数的0.6%)在麻醉诱导时发生心脏骤停,3天后死亡。
关键数值与推荐
- 严重左心室肥厚定义为最大室壁厚度>30 mm,共23例(14%)。
- 血流动力学显著的LVOT压差定义为>50 mm Hg,共35例(21%)。
- 轻微围术期并发症包括低血压(15例)、心动过缓(4例)和短暂ST段改变(1例);围术期死亡1例(0.6%)。
临床怎么用
- 在专家中心,HCM患儿可接受全身麻醉,围术期死亡与轻微并发症发生率相对较低,麻醉方案可参考本中心经验。
- 术前应评估最大室壁厚度与LVOT压差,但本研究提示这些参数未与并发症风险升高相关,不能单独用于风险分层。
局限性
- 为单中心回顾性研究,样本量有限(86例患儿、164次麻醉)。
- 原文指出未来需系统识别可预测麻醉风险的临床特征,当前证据尚不足以建立预测模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Children with hypertrophic cardiomyopathy (HCM) have historically been considered to be high-risk candidates for general anaesthesia (GA), but there is currently a paucity of evidence regarding the safety of anaesthesia and perioperative outcomes in this population. METHODS: Clinical features and outcomes of all paediatric patients (<18 years) with HCM undergoing GA between 2000 and 2016 were reviewed. RESULTS: 86 patients (median 12.4 years (IQR 6.5, 14.9)) underwent 164 separate GA procedures. Aetiology included non-syndromic disease (n=44, 56%), malformation syndromes (n=22, 26%), inborn error of metabolism (n=10, 12%) and neuromuscular disease (n=4, 5%). At the time of GA, mean maximal wall thickness (MWT) on echocardiography was 19 mm (SD±8 mm), 23 (14%) patients had severe left ventricular hypertrophy (MWT>30 mm) and 35 (21%) patients had a haemodynamically significant left ventricular outflow tract (LVOT) gradient (>50 mm Hg). The majority (n=143, 87%) had no perioperative complications. 20 (12%) patients had minor perioperative complications: bradycardia (n=4), hypotension (n=15) or transient ST segment changes (n=1). One (0.6% of GA procedures) patient experienced a cardiac arrest during anaesthetic induction with death occurring 3 days later. Clinical parameters (including age, MWT, LVOT gradient, systolic and diastolic dysfunction) were not associated with an increased risk of complications CONCLUSIONS: This is the largest published series to date of paediatric patients with HCM undergoing GA, which demonstrates that, in an expert centre, patients can be anaesthetised with a relatively low perianaesthetic mortality (0.6%) and prevalence of minor complications (12%). Future studies are required to systematically identify clinical features that may predict anaesthetic risk.
引用
- Norrish G, Forshaw N, Woo C, et al. Outcomes following general anaesthesia in children with hypertrophic cardiomyopathy. Arch Dis Child. 2018. PMID: 30413484. doi:10.1136/archdischild-2018-315366
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。